Cystic Fibrosis Screening

NewsGuard 100/100 Score

Cystic fibrosis screening test results are based on determination of heterogeneous circulating forms of immunoreactive trypsinogen (IRT) and the most common cystic fibrosis mutation that is usually associated with severe cystic fibrosis disease, ∆F508. Newborn screening will not detect all forms of cystic fibrosis; IRT testing may miss patients with pancreatic sufficiency. Because IRT values decrease as a baby ages, IRT results are not reliable after 90 days, so prompt repeat screening is essential. The screening tests are an adjunct to clinical assessment, which is paramount. cystic fibrosis should be considered in infants with any of the signs and symptoms of the disease.

It is essential to confirm or exclude the diagnosis of cystic fibrosis in a timely fashion to avoid unnecessary testing, to provide appropriate interventions, prognostic and genetic counseling, and to ensure access to specialized medical services. In most cases the diagnosis of cystic fibrosis will be confirmed by measurement of chloride concentrations in pharmacologically-stimulated sweat. Because newborns may not produce enough sweat for a reliable diagnosis in the first weeks of life, consultation with a pulmonary specialist is essential. Genetic testing may be performed.

Cystic fibrosis cannot be cured, but many symptoms can be treated. Many newborns with meconium ileus will need surgery shortly after birth. Most children and adults with cystic fibrosis will need to eat a healthy, high-calorie diet and take vitamins to help them grow. Some people may also need medications to help them get more nutrients from the food they eat. To breathe better, many people with cystic fibrosis need help clearing mucus from their lungs each day. Some medications can also prevent infections and help with breathing. The Newborn Screening Program recommends that all babies with cystic fibrosis be treated in an accredited cystic fibrosis Center. Children with cystic fibrosis and their families also benefit from having a primary care physician who helps to coordinate their care with medical specialists and other community-based services.

Further Reading

Last Updated: Jun 5, 2019

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2019, June 05). Cystic Fibrosis Screening. News-Medical. Retrieved on March 04, 2024 from

  • MLA

    Mandal, Ananya. "Cystic Fibrosis Screening". News-Medical. 04 March 2024. <>.

  • Chicago

    Mandal, Ananya. "Cystic Fibrosis Screening". News-Medical. (accessed March 04, 2024).

  • Harvard

    Mandal, Ananya. 2019. Cystic Fibrosis Screening. News-Medical, viewed 04 March 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Breakthrough discovery offers hope for reducing infections in cystic fibrosis patients